Matthew G. Manders - 13 May 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Matt Manders, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
13 May 2025
Net transactions value
$0
Form type
4
Filing time
15 May 2025, 18:15:20 UTC
Previous filing
14 May 2024
Next filing
06 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Manders Matthew G Director C/O NEUEHEALTH, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS /s/ Eric Halverson for Matt Manders, Attorney-in-Fact 15 May 2025 0001480601

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise $0 +10,500 +168% $0.000000 16,741 13 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -10,500 -100% $0.000000 0 13 May 2025 Common Stock 10,500 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 All of these restricted stock units vested on May 13, 2025, one year from the grant date.